This is not the most recent version of this material.
For an updated version, please see the relevant topic page.
Multiple Sclerosis: Evidence Report
ICER’s Evidence Report on disease-modifying therapies for multiple sclerosis. This report will the subject of a February 2017 meeting of the California Technology Assessment Forum.View All Materials on this Topic or Go Back to View More Materials